Literature DB >> 20432235

Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.

Keri L Schaubert1, David A Price, Janelle R Salkowitz, Andrew K Sewell, John Sidney, Tedi E Asher, Sylvie E Blondelle, Sharon Adams, Francesco M Marincola, Aviva Joseph, Alessandro Sette, Daniel C Douek, Velpandi Ayyavoo, Walter Storkus, Ming-Ying Leung, Hwee L Ng, Otto O Yang, Harris Goldstein, Darcy B Wilson, June Kan-Mitchell.   

Abstract

HLA-A 0201-restricted virus-specific CD8(+) CTL do not appear to control HIV effectively in vivo. To enhance the immunogenicity of a highly conserved subdominant epitope, TV9 (TLNAWVKVV, p24 Gag(19-27)), mimotopes were designed by screening a large combinatorial nonapeptide library with TV9-specific CTL primed in vitro from healthy donors. A mimic peptide with a low binding affinity to HLA-A 0201, TV9p6 (KINAWIKVV), was studied further. Parallel cultures of in vitro-primed CTL showed that TV9p6 consistently activated cross-reactive and equally functional CTL as measured by cytotoxicity, cytokine production and suppression of HIV replication in vitro. Comparison of TCRB gene usage between CTL primed from the same donors with TV9 or TV9p6 revealed a degree of clonal overlap in some cases and an example of a conserved TCRB sequence encoded distinctly at the nucleotide level between individuals (a "public" TCR); however, in the main, distinct clonotypes were recruited by each peptide antigen. These findings indicate that mimotopes can mobilize functional cross-reactive clonotypes that are less readily recruited from the naïve T-cell pool by the corresponding WT epitope. Mimotope-induced repertoire diversification could potentially override subdominance under certain circumstances and enhance vaccine-induced responses to conserved but poorly immunogenic determinants within the HIV proteome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432235      PMCID: PMC3086652          DOI: 10.1002/eji.200940079

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  46 in total

1.  Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.

Authors:  Michael S Bennett; Hwee L Ng; Mirabelle Dagarag; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

2.  Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.

Authors:  Florian Bihl; Nicole Frahm; Loriana Di Giammarino; John Sidney; Mina John; Karina Yusim; Tonia Woodberry; Kaori Sango; Hannah S Hewitt; Leah Henry; Caitlyn H Linde; John V Chisholm; Tauheed M Zaman; Eunice Pae; Simon Mallal; Bruce D Walker; Alessandro Sette; Bette T Korber; David Heckerman; Christian Brander
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 3.  Mimotope vaccines for cancer immunotherapy.

Authors:  Tumenjargal Sharav; Karl-Heinz Wiesmüller; Peter Walden
Journal:  Vaccine       Date:  2007-01-22       Impact factor: 3.641

4.  The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2.

Authors:  Malcolm S Mitchell; Teri A Lund; Andrew K Sewell; Francesco M Marincola; Elyse Paul; Kim Schroder; Darcy B Wilson; June Kan-Mitchell
Journal:  Cancer Immunol Immunother       Date:  2006-07-28       Impact factor: 6.968

Review 5.  Establishment and recall of CD8+ T-cell memory in a model of localized transient infection.

Authors:  Katherine Kedzierska; Nicole L La Gruta; Stephen J Turner; Peter C Doherty
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

6.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

Review 7.  The T cell repertoire in infection and vaccination: implications for control of persistent viruses.

Authors:  Miles P Davenport; David A Price; Andrew J McMichael
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

8.  Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference.

Authors:  Natasha Larke; Eung-Jun Im; Ralf Wagner; Carolyn Williamson; Anna-Lise Williamson; Andrew J McMichael; Tomás Hanke
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

9.  Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.

Authors:  June Kan-Mitchell; Melissa Bajcz; Keri L Schaubert; David A Price; Jason M Brenchley; Tedi E Asher; Daniel C Douek; Hwee L Ng; Otto O Yang; Charles R Rinaldo; Jose Miguel Benito; Brygida Bisikirska; Ramakrishna Hegde; Franco M Marincola; César Boggiano; Dianne Wilson; Judith Abrams; Sylvie E Blondelle; Darcy B Wilson
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

10.  Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Authors:  Linda Wooldridge; Anna Lissina; Jonathan Vernazza; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Fareed Mirza; P Rod Dunbar; Jonathan M Boulter; Meir Glick; Vincenzo Cerundolo; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

View more
  11 in total

1.  Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

2.  Rapid, efficient functional characterization and recovery of HIV-specific human CD8+ T cells using microengraving.

Authors:  Navin Varadarajan; Douglas S Kwon; Kenneth M Law; Adebola O Ogunniyi; Melis N Anahtar; James M Richter; Bruce D Walker; J Christopher Love
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

3.  Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.

Authors:  Zaza M Ndhlovu; Alicja Piechocka-Trocha; Seanna Vine; Ashley McMullen; Kegakilwe C Koofhethile; Phillip J R Goulder; Thumbi Ndung'u; Dan H Barouch; Bruce D Walker
Journal:  J Immunol       Date:  2011-05-16       Impact factor: 5.422

Review 4.  Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.

Authors:  Emanuela M Iancu; Petra Baumgaertner; Sébastien Wieckowski; Daniel E Speiser; Nathalie Rufer
Journal:  J Biomed Biotechnol       Date:  2010-11-14

5.  Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.

Authors:  S D Soysal; S Muenst; J Kan-Mitchell; E Huarte; X Zhang; I Wilkinson-Ryan; T Fleming; V Tiriveedhi; T Mohanakumar; L Li; J Herndon; D Oertli; S P Goedegebuure; W E Gillanders
Journal:  Breast Cancer Res Treat       Date:  2014-09-12       Impact factor: 4.872

6.  T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes.

Authors:  Amalie K Bentzen; Lina Such; Kamilla K Jensen; Andrea M Marquard; Leon E Jessen; Natalie J Miller; Candice D Church; Rikke Lyngaa; David M Koelle; Jürgen C Becker; Carsten Linnemann; Ton N M Schumacher; Paolo Marcatili; Paul Nghiem; Morten Nielsen; Sine R Hadrup
Journal:  Nat Biotechnol       Date:  2018-11-19       Impact factor: 68.164

Review 7.  Empirical and Rational Design of T Cell Receptor-Based Immunotherapies.

Authors:  Heather F Jones; Zaki Molvi; Martin G Klatt; Tao Dao; David A Scheinberg
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

8.  HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection.

Authors:  Victor Y Du; Anju Bansal; Jonathan Carlson; Jesus F Salazar-Gonzalez; Maria G Salazar; Kristin Ladell; Stephanie Gras; Tracy M Josephs; Sonya L Heath; David A Price; Jamie Rossjohn; Eric Hunter; Paul A Goepfert
Journal:  J Immunol       Date:  2016-03-16       Impact factor: 5.422

9.  The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses.

Authors:  Weidong Xu; Douglas M Watts; Margaret C Costanzo; Xiaolei Tang; Leon A Venegas; Feng Jiao; Alessandro Sette; John Sidney; Andrew K Sewell; Linda Wooldridge; Shinji Makino; John C Morrill; Clarence J Peters; June Kan-Mitchell
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

10.  T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.

Authors:  Julia Ekeruche-Makinde; Mathew Clement; David K Cole; Emily S J Edwards; Kristin Ladell; John J Miles; Katherine K Matthews; Anna Fuller; Katy A Lloyd; Florian Madura; Garry M Dolton; Johanne Pentier; Anna Lissina; Emma Gostick; Tiffany K Baxter; Brian M Baker; Pierre J Rizkallah; David A Price; Linda Wooldridge; Andrew K Sewell
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.